Session | Presenters | Title |
1a - Good, bad or indistinguishable: Quality of care and innovations in the private sector | Raman Sohal, Kate Mossman | Performance masurement in low- and middle-income countries: Developing credible and feasible measures to evaluate innovative private sector programs |
1a - Good, bad or indistinguishable: Quality of care and innovations in the private sector | Yen Thi Kim Le | Demand side financing to increase access to sexual reproductive health and family planning services amongst youth, migrant workers and low income women in Vietnam |
1b - Building institutions for influencing private sector performance | Han Win Htat | A Total Market Approach for condoms in Myanmar: How the private, socially marketed, and public sectors can work together for a sustainable future for HIV prevention |
1b - Building institutions for influencing private sector performance | Oanh Tran Thi Mai | Performance of private providers towards primary health care services in rural areas of Vietnam and gaps for interventions |
1b - Building institutions for influencing private sector performance | Shakil Ahmed | Strengthening community-based maternal health care delivery systems in Thakurgoan district of Bangladesh: Promising public-private partnerships |
1b - Building institutions for influencing private sector performance | Jane Doherty | Regulating the for-profit private sector: Lessons from East and Southern Africa |
1c - Good, bad or indistinguishable: Quality of care in the private sector | Nilmini Wijemanne | The quality of inpatient care in Sri Lanka – how good is it and how does it differ between public and private sectors? |
1c - Good, bad or indistinguishable: Quality of care in the private sector | Camilo Cid Pedraza | Clinical outcomes in hospitals with public, private not-for-profit and private for-profit ownership in Chile 2001-2010 |
1c - Good, bad or indistinguishable: Quality of care in the private sector | Nilmini Wijemanne | The quality of outpatient care in public and private sectors in Sri Lanka – how well do patient perceptions match reality and what are the implications? |
1c - Good, bad or indistinguishable: Quality of care in the private sector | Karen Eggleston | Collaborative governance in the health systems of China and the United States |
1d - Health markets and the poor: Moving toward universal access? | Zhang Yan | Indicate the trends of compensation level of the National Health Insurance System by means of Total Health Expenditure: A case of China |
2a - Health markets and the poor: Moving towards universal access? | Anuradha Katyal | Rajiv Aarogyasri Health Insurance Scheme - health financing for the unreached population for procedures deemed expensive |
2a - Health markets and the poor: Moving towards universal access? | San San Aye | Role of private sector in Myanmar’s health care system: Implications for health sector reform |
2a - Health markets and the poor: Moving towards universal access? | George Gotsadze | Purchasing private health insurance for the poor in Georgia: Preliminary results and policy implications |
2a - Health markets and the poor: Moving towards universal access? | Emily Zimmerman | Using research on the value of health microinsurance to inform product design: The case of Banrural, Guatemala |
2b - Building institutions for influencing private sector performance | Lucy Kanya | Spending on quality: Use of voucher revenue at accredited facilities in Kenya |
2b - Building institutions for influencing private sector performance | Chen Gao | Patient satisfaction for health care: Does ownership matter? |
2c - Good, bad or indistinguishable: Quality of care in the private sector | Ilana Ron Levey | Estimating the effects of financial and non-financial incentives on private sector health worker motivation: A national study in Malawi |
2c - Good, bad or indistinguishable: Quality of care in the private sector | Chengxiang Tang | Differences in length of stay and medical cost between public and private hospitals in China |
2c - Good, bad or indistinguishable: Quality of care in the private sector | Minki Chatterji | Mobile phone messages to increase prescription of Zinc by private sector Chemical Sellers in Ghana – A randomized controlled trial |
2c - Good, bad or indistinguishable: Quality of care in the private sector | Minki Chatterji | What is the impact of evidence-based medicine (EBM) on family planning providers’ knowledge, attitudes, and practice behaviors? A randomized experiment in Jordan |
2d - Equity | Nirali Chakraborty | Measuring Equity- Without Tears: Aligning equity measures across organizations |
2d - Equity | David Hotchkiss | Does an expansion of private sector provision of facility-based deliveries increase horizontal inequity in service use?: Evidence from Nepal and Bangladesh |
2d - Equity | Suneeta Sharma | Scaling-up proven public private partnership models to achieve family planning equity goals in India |
2d - Equity | Rubana Islam | Who serves the poor? |
3a - Good, bad, or indistinguishable: Quality of care in the private sector | Anna Y. De La Cruz | The impact of Clinical Social Franchising on health services in low- and middle-income countries: A systematic review |
3a - Good, bad, or indistinguishable: Quality of care in the private sector | Raman Sohal, Kate Mossman | Maternal, newborn, and child health: Exploring and evaluating private sector innovations in low- and middle-income countries |
3a - Good, bad, or indistinguishable: Quality of care in the private sector | Douglas Johnson | Conducting censuses of private health facility: Lessons from ten countries |
3a - Good, bad, or indistinguishable: Quality of care in the private sector | Zachary Wagner | Private sector provision of oral rehydration for child Diarrhea in Sub-Saharan Africa |
3b - The evolution of the global health marketplace: Implications for health systems | Krishna Hort | The role of the private sector in contributing to public health service goals: ideology or evidence? |
3b - The evolution of the global health marketplace: Implications for health systems | Andreasta Meliala | The geographic distribution of specialist doctors in a mixed public- private system: Regulatory challenges for Indonesia |
3c - Paying for private care: The private sector and health financing | Kameko Nichols | Review of innovative methods to finance capital investment in transportation and align PPP incentives to improve health care delivery in The Gambia |
3c - Paying for private care: The private sector and health financing | Lipika Ahuja | Private capital investment in primary care - a study of three equity financed primary care chains in India |
3c - Paying for private care: The private sector and health financing | Eric Keuffel | Price differentiation in low- and middle-income pharmaceutical markets |
3d - Paying for private care: The private sector and health financing | Ilana Ron Levey | Reducing the cost of private sector ARVs in Namibia: A means to increase access |
3d - Paying for private care: The private sector and health financing | Kara Hanson | Retail pricing of antimalarial drugs under the Affordable Medicines Facility – malaria: Exploring the effect of an innovative approach to financing antimalarials in the private sector to improve equity and increase access |
3d - Paying for private care: The private sector and health financing | Kristian Schultz Hansen | Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda |